div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: myeloma or blood plasma cancer is characterized by increased blood vessel formulation in the bone marrow that is a prognostic factor in survival src=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: myeloma or blood plasma cancer is characterized by increased blood vessel formulation in the bone marrow that is a prognostic factor in survival src=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: myeloma or blood plasma cancer is characterized by increased blood vessel formulation in the bone marrow that is a prognostic factor in survival src=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 4button div class=ts-image a href=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5page4jpg target=_blank amp-img class=ts-thumb alt=Page 4: myeloma or blood plasma cancer is characterized by increased blood vessel formulation in the bone marrow that is a prognostic factor in survival src=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 5button div class=ts-image a href=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5page5jpg target=_blank amp-img class=ts-thumb alt=Page 5: myeloma or blood plasma cancer is characterized by increased blood vessel formulation in the bone marrow that is a prognostic factor in survival src=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5thumbnails5jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 6button div class=ts-image a href=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5page6jpg target=_blank amp-img class=ts-thumb alt=Page 6: myeloma or blood plasma cancer is characterized by increased blood vessel formulation in the bone marrow that is a prognostic factor in survival src=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5thumbnails6jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 7button div class=ts-image a href=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5page7jpg target=_blank amp-img class=ts-thumb alt=Page 7: myeloma or blood plasma cancer is characterized by increased blood vessel formulation in the bone marrow that is a prognostic factor in survival src=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5thumbnails7jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 8button div class=ts-image a href=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5page8jpg target=_blank amp-img class=ts-thumb alt=Page 8: myeloma or blood plasma cancer is characterized by increased blood vessel formulation in the bone marrow that is a prognostic factor in survival src=https:reader042vdocumentsusreader042viewer20220225035ab2cc977f8b9a6b468dd151html5thumbnails8jpg width=142 height=106 layout=responsive amp-imga divdiv